Literature DB >> 20107186

Transient receptor potential melastatin 2 is required for lipopolysaccharide-induced cytokine production in human monocytes.

Janine Wehrhahn1, Robert Kraft, Christian Harteneck, Sunna Hauschildt.   

Abstract

Transient receptor potential melastatin 2 (TRPM2) is a Ca(2+)-permeable nonselective cation channel that is stimulated by oxidative stress and specifically activated by intracellular ADP-ribose. Because TRPM2 is highly expressed in immunocytes, a role of this channel in inflammation processes has been proposed. The aim of the current study was to determine the function of TRPM2 in LPS-induced cytokine production of human monocytes. Incubation of human primary monocytes with LPS resulted in an upregulation of TRPM2 mRNA, protein, and of ADP-ribose-induced membrane currents. By using short hairpin RNA to downregulate TRPM2 expression in THP-1 monocytes, we demonstrate that TRPM2 is required for the LPS-induced production of IL-6, IL-8, IL-10, and TNF-alpha. Application of LPS led to a time-dependent increase in intracellular Ca(2+) concentrations in THP-1 cells that was clearly reduced by downregulation of TRPM2. Omission of extracellular Ca(2+) strongly decreased TNF-alpha production in TRPM2-expressing cells. Thus, TRPM2-mediated Ca(2+) entry is a central mechanism for LPS-induced cytokine production in monocytic cells. The identification of TRPM2 as a major player in this LPS-dependent process makes it a promising tool in modulating monocyte functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107186     DOI: 10.4049/jimmunol.0902474

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  TRPM channels: same ballpark, different players, and different rules in immunogenetics.

Authors:  Ammad Ahmad Farooqi; Mohammed Khalid Javeed; Zeeshan Javed; Asma M Riaz; Shahzeray Mukhtar; Sehrish Minhaj; Sana Abbas; Shahzad Bhatti
Journal:  Immunogenetics       Date:  2011-09-20       Impact factor: 2.846

2.  Pharmacological comparison of novel synthetic fenamate analogues with econazole and 2-APB on the inhibition of TRPM2 channels.

Authors:  Gui-Lan Chen; Bo Zeng; Sarah Eastmond; Sandra E Elsenussi; Andrew N Boa; Shang-Zhong Xu
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  What is the evidence for the role of TRP channels in inflammatory and immune cells?

Authors:  A Parenti; F De Logu; P Geppetti; S Benemei
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

4.  Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes.

Authors:  Heather Knowles; Justin W Heizer; Yuan Li; Kathryn Chapman; Carol Anne Ogden; Karl Andreasen; Ellen Shapland; Gary Kucera; Jennifer Mogan; Jessica Humann; Laurel L Lenz; Alastair D Morrison; Anne-Laure Perraud
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

5.  Glucagon-like peptide-1 potentiates glucose-stimulated insulin secretion via the transient receptor potential melastatin 2 channel.

Authors:  Bo Pang; Sungjoon Kim; Daiqing Li; Zejun Ma; Bei Sun; Xiaona Zhang; Zhongming Wu; Liming Chen
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

6.  Luteolin activates ERK1/2- and Ca2+-dependent HO-1 induction that reduces LPS-induced HMGB1, iNOS/NO, and COX-2 expression in RAW264.7 cells and mitigates acute lung injury of endotoxin mice.

Authors:  Eun Jung Park; Young Min Kim; Hye Jung Kim; Ki Churl Chang
Journal:  Inflamm Res       Date:  2018-03-01       Impact factor: 4.575

Review 7.  The TRPM2 ion channel, an oxidative stress and metabolic sensor regulating innate immunity and inflammation.

Authors:  Heather Knowles; Yuan Li; Anne-Laure Perraud
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

Review 8.  Nociceptive Roles of TRPM2 Ion Channel in Pathologic Pain.

Authors:  Yongwoo Jang; Pyung Sun Cho; Young Duk Yang; Sun Wook Hwang
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

9.  Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.

Authors:  Chihab Klose; Isabelle Straub; Marc Riehle; Felicia Ranta; Dietmar Krautwurst; Susanne Ullrich; Wolfgang Meyerhof; Christian Harteneck
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 10.  Macrophage function in atherosclerosis: potential roles of TRP channels.

Authors:  Jean-Yves K Tano; Robert H Lee; Guillermo Vazquez
Journal:  Channels (Austin)       Date:  2012 May-Jun       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.